ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) takes part in 3 sessions at ESMO 2026 in Madrid. Its work spans genitourinary cancers and rare tumours, including brain cancer. It examines germ cell and kidney cancer outcomes, as well as how a selenium-containing gelatin material acts in glioblastoma.
| Organization | ESMO 2026 Attendance |
|---|---|
AC Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) Navi Mumbai, India | |
Cancer research, treatment and education centre in Navi Mumbai, India. | Poster Fri Oct 23 13:00–15:00 Does S3 tumor markers and non-pulmonary visceral metastases confer similar outcome in poor-risk non-seminomatous germ cell tumors (NSGCT)? An analysis of long-term outcomes from Indian subcontinent Genitourinary cancersSarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 13:00–15:00 Selenogelatin (GSeSeG), a diselenide-functionalized gelatin biomaterial, and its nanocomposite: A multi-omics mechanistic characterization in glioblastoma multiforme Sarcoma, CNS, head & neck and rare cancers Poster Fri Oct 23 15:15–16:00 Can low-dose nivolumab improve survival in intermediate and poor risk metastatic clear cell renal cell carcinoma? A real-world LMIC experience Genitourinary cancersSarcoma, CNS, head & neck and rare cancers |
Find decision makers at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)
Tell us what you sell and we’ll find the people at Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction